FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) e...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

NHS Improvement National Patient Safety Alert: Inappropriate anticoagulation of patients with a mechanical heart valve
NHS Improvement has published details of a National Patient Safety Alert around inappropriate anticoagulation of patients with a mechanical heart valve. Incidents have been reported of patients with (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 14, 2021 Category: Drugs & Pharmacology Source Type: news

Psychiatry Is Still Stuck in Freud ’s Era. Big Data Can Revolutionize How We Care for Patients
I have a problem. I am a psychiatrist in the 21st century and yet I still evaluate patients the way Freud did a century ago: I sit with a patient and, by carefully observing how and what they say, I expect them to tell me what’s wrong. The problem isn’t that I speak with and listen to my patients. Every doctor of every speciality does that. Rather, my problem is that I never measure the data I think are most important to my treatment of psychiatric diseases. Consider how I evaluate a patient for psychosis in the emergency room. When I speak with them, I want to know what their life is like—what’s th...
Source: TIME: Health - July 9, 2021 Category: Consumer Health News Authors: Daniel Barron Tags: Uncategorized Source Type: news

RSNA announces 2021 meeting highlights
The RSNA has announced program highlights ahead of its 2021 annual meeting t...Read more on AuntMinnie.comRelated Reading: RSNA announces MIDRC funding program RSNA R&E grant study identifies new biomarker for NSCLC RSNA plans for in-person meeting in 2021 Top healthcare trends on display at RSNA 2020 FDG-PET/CT within a year of heart valve surgery looks safe (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 24, 2021 Category: Radiology Source Type: news

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

No Benefit to Postop Heparin Bridging in Patients Who Stop Warfarin for a Procedure No Benefit to Postop Heparin Bridging in Patients Who Stop Warfarin for a Procedure
There does not appear to be a benefit to postoperative heparin bridging in patients with atrial fibrillation or a mechanical heart valve who temporarily stop taking warfarin before a planned procedure, according to results of the PERIOP2 study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 18, 2021 Category: Surgery Tags: Cardiology News Source Type: news

Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: After Two Heart Valve Surgeries, a Mental Toll
Title: AHA News: After Two Heart Valve Surgeries, a Mental TollCategory: Health NewsCreated: 4/20/2021 12:00:00 AMLast Editorial Review: 4/21/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - April 21, 2021 Category: Cardiology Source Type: news

AHA News: After Two Heart Valve Surgeries, a Mental Toll
TUESDAY, April 20, 2021 (American Heart Association News) -- After Ivan Hernandez was born with a defective mitral valve, doctors warned his parents he could face heart failure at any age. Yet Hernandez grew up without incident. He played all sorts... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 20, 2021 Category: General Medicine Source Type: news

Abbott Receives CE Mark Approval for Next-Generation TriClip(TM) Device, Offering New Innovations for Tricuspid Heart Valve Repair
New enhancements to first-of-its-kind device uniquely developed for the difficult-to-treat tricuspid valve Next-generation therapy offers enhanced leaflet grasping feature and new clip sizes to fit each patient's complex tricuspid valve anatomy TriCl... Devices, Interventional, Cardiology, Regulatory Abbott, TriClip, Transcatheter, Tricuspid Valve Repair, Tricuspid Valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 8, 2021 Category: Pharmaceuticals Source Type: news

Abbott Receives CE Mark Approval for Next-Generation TriClip ™ Device, Offering New Innovations for Tricuspid Heart Valve Repair
- New enhancements to first-of-its-kind device uniquely developed for the difficult-to-treat tricuspid valve (Source: Abbott.com)
Source: Abbott.com - April 8, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves First Nonsurgical Heart Valve for Congenital Heart Disease
MONDAY, March 29, 2021 -- The first-ever nonsurgical heart valve to treat patients with severe pulmonary valve regurgitation, often resulting from congenital heart disease, was approved by the U.S. Food and Drug Administration, the agency announced... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 29, 2021 Category: Pharmaceuticals Source Type: news

Lab-Made Heart Valves Can Grow Along With Youngest Heart Patients
MONDAY, March 22, 2021 -- Lab-created heart valves that grow with the recipient could spare kids born with heart defects from the repeated valve-replacement surgeries they now endure. University of Minnesota researchers found that lab-created valves... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 22, 2021 Category: General Medicine Source Type: news

Lab-Made Heart Valves Can Grow Along With Youngest Heart Patients
Title: Lab-Made Heart Valves Can Grow Along With Youngest Heart PatientsCategory: Health NewsCreated: 3/22/2021 12:00:00 AMLast Editorial Review: 3/22/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 22, 2021 Category: Cardiology Source Type: news

Artificial Heart Valves Grow with Lambs
Two of the implanted valves lasted a full year as the animals matured into adult sheep, demonstrating that it might be possible to treat children with valve replacements that grow along with them. (Source: The Scientist)
Source: The Scientist - March 19, 2021 Category: Science Tags: News & Opinion Source Type: news

Tri-tube heart valve replacement adapts to the growing heart in lambs
(American Association for the Advancement of Science) Combining tissue engineering and regenerative medicine, scientists have fabricated a series of heart valve replacements with the ability to incorporate host cells, enabling them to regenerate and grow over time. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 17, 2021 Category: International Medicine & Public Health Source Type: news

Lab-created heart valves can grow with the recipient
(University of Minnesota) Groundbreaking discovery could potentially reduce multiple pediatric heart valve replacement surgeries. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 17, 2021 Category: Biology Source Type: news

DOACs Offered After Heart Valve Surgery Despite Absence of Data DOACs Offered After Heart Valve Surgery Despite Absence of Data
Use of direct oral anticoagulants (DOACs), contraindicated for patients with mechanical or bioprosthetic valves, has increased steadily for surgical bioprosthetic valve replacement.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 10, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Aortic calcification: An early sign of heart valve problems?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - February 19, 2021 Category: Consumer Health News Source Type: news

Heart Valve Collaboratory announces U.S. FDA participation in collaborative community
(Cardiovascular Research Foundation) The Heart Valve Collaboratory (HVC) announced today that the U.S. Food and Drug Administration (FDA)'s Center for Devices and Radiological Health (CDRH) will participate in this " collaborative community " . A medical " collaboratory " is a forum in which multidisciplinary private and public sector members work together on medical device challenges to achieve aligned outcomes, solve shared problems, and leverage collective opportunities, in the interest of improving patient care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 16, 2021 Category: International Medicine & Public Health Source Type: news

Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease
Mapping the gene-regulatory networks dysregulated in human disease would allow the design of network-correcting therapies that treat the core disease mechanism. However, small molecules are traditionally screened for their effects on one to several outputs at most, biasing discovery and limiting the likelihood of true disease-modifying drug candidates. Here, we developed a machine-learning approach to identify small molecules that broadly correct gene networks dysregulated in a human induced pluripotent stem cell (iPSC) disease model of a common form of heart disease involving the aortic valve (AV). Gene network correction...
Source: ScienceNOW - February 11, 2021 Category: Science Authors: Theodoris, C. V., Zhou, P., Liu, L., Zhang, Y., Nishino, T., Huang, Y., Kostina, A., Ranade, S. S., Gifford, C. A., Uspenskiy, V., Malashicheva, A., Ding, S., Srivastava, D. Tags: Genetics, Medicine, Diseases, Online Only r-articles Source Type: news

Breakthrough design at UBCO vastly improves mechanical heart valve
(University of British Columbia Okanagan campus) New research coming out of UBC's Okanagan campus may take the current 'gold standard' for heart valves to a new level of reliability.A team of researchers at UBCO's Heart Valve Performance Lab (HVPL) has developed a way to improve overall blood flow through the valves, so the design of mechanical heart valves will more closely match the real thing. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 26, 2021 Category: International Medicine & Public Health Source Type: news

A potential therapy for one of the leading causes of heart disease
(Gladstone Institutes) After 15 years of unrelenting work, a team of scientists from Gladstone Institutes has discovered a potential drug candidate for heart valve disease that works in both human cells and animals and is ready to move toward a clinical trial. Their findings were just published in the journal Science. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2020 Category: International Medicine & Public Health Source Type: news

Huge gap in demand, supply of organs for transplant in country: AIIMS chief
AIIMS Director Dr Randeep Guleria said the AIIMS was working to "very soon" start a lung transplant programme even as it has facilities available for transplantation of heart, kidney, liver, pancreas, cornea, heart valve and bones. (Source: The Economic Times)
Source: The Economic Times - November 27, 2020 Category: Consumer Health News Source Type: news

What Does a Leaky Heart Valve Feel Like?
Title: What Does a Leaky Heart Valve Feel Like?Category: Diseases and ConditionsCreated: 11/10/2020 12:00:00 AMLast Editorial Review: 11/10/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 10, 2020 Category: Cardiology Source Type: news

New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need f...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

OrbusNeich(R) Medical and P+F Products and Features(R) announce new partnership
Introducing a new portfolio of heart valve products aiming to restore health and extend life HONG KONG, Nov. 9, 2020 -- (Healthcare Sales & Marketing Network) -- OrbusNeich and P+F today announced they have entered into an agreement for the exclusive d... Devices, Interventional, Cardiology, Distribution OrbusNeich Medical, P+F, heart valve, TricValve, Bicaval Valves (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2020 Category: Pharmaceuticals Source Type: news

Scientists Have Uncovered the Likely Cause of a Serious COVID-19 Symptom: Blood Clotting
One of the more surprising symptoms of COVID-19 has been the blood clots that many patients, including younger ones, have experienced with the infection. The clots have in some cases led to dangerous blockages in the lungs, caused strokes and even death, even in people without a history of circulatory conditions. In a paper published in Science earlier this week, researchers provide a glimpse into what may be driving the clots triggered by COVID-19 infection. The group found that a specific set of antibodies known as autoantibodies—which are rogue versions of cells meant to defend the body from pathogens, but instead...
Source: TIME: Health - November 5, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

How Long Can You Live With Heart Valve Disease?
Title: How Long Can You Live With Heart Valve Disease?Category: Diseases and ConditionsCreated: 11/3/2020 12:00:00 AMLast Editorial Review: 11/3/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 3, 2020 Category: Cardiology Source Type: news

Opioid epidemic leads to more, younger people having heart valve operations
ROCHESTER, Minn. ? The opioid epidemic in the U.S. is becoming a bigger problem medically, socially and financially, and the COVID-19 pandemic has made it worse, according to the Food and Drug Administration. Heart surgeons have seen a disturbing trend over the past decade: more and younger patients with infective endocarditis requiring heart surgery. Infective [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - October 28, 2020 Category: Hospital Management Source Type: news

Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revasculariz...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Survival Rate of Heart Valve Replacement Surgery
Title: Survival Rate of Heart Valve Replacement SurgeryCategory: Diseases and ConditionsCreated: 10/23/2020 12:00:00 AMLast Editorial Review: 10/23/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 23, 2020 Category: Cardiology Source Type: news

Leaflet Immobility and Thrombosis in TAVR Leaflet Immobility and Thrombosis in TAVR
How common is subclinical transcatheter heart valve thrombosis following TAVR? What are the potential clinical implications, and how should these patients be managed?European Heart Journal (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 14, 2020 Category: Radiology Tags: Cardiology Journal Article Source Type: news

Abbott Receives CE Mark for Next-Generation MitraClip ™ Heart Valve Repair Device to Treat Mitral Regurgitation
- CE Mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology (Source: Abbott.com)
Source: Abbott.com - September 21, 2020 Category: Pharmaceuticals Source Type: news

Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care, Heart
Guidance is presented on identification of stable patients that could have follow-up deferred safely and suggest certain patients that could be discharged from follow-up if waiting lists are triaged with appropriate clinical input. Novel models of working are also proposed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 2, 2020 Category: Consumer Health News Source Type: news

Research brief: Researchers 3D print lifelike heart valve models
(University of Minnesota) Researchers from the University of Minnesota, with support from Medtronic, have developed a groundbreaking process for multi-material 3D printing of lifelike models of the heart's aortic valve and the surrounding structures that mimic the exact look and feel of a real patient. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 28, 2020 Category: Biology Source Type: news

AHA News: Black People Get Fewer Heart Valve Replacements, But Inequity Gap Is Narrowing
TUESDAY, Aug. 11, 2020 (American Heart Association News) -- Black people with severely malfunctioning heart valves are less likely than their white peers to receive lifesaving valve replacements, according to a new study. The study, published... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 11, 2020 Category: General Medicine Source Type: news

Janssen Announces U.S. FDA Approval of SPRAVATO ® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior
TITUSVILLE, N.J. – (August 3, 2020) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation orbehavior.1 SPRAVATO® is the first and only approved medicine that has been shown to reduce depressive symptoms within 24 hours,1 providing a new option for significant symptom relief until a longer-te...
Source: Johnson and Johnson - August 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Engineers find thinner tissues in replacement heart valves create problematic flutter
(Iowa State University) Iowa State and University of Texas engineers have developed high-fidelity computational models of replacement heart valves to examine the performance of biological tissues built into the valves. They found that thinner tissues can flap and flutter, which can damage the valves and even the blood that flows by. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 29, 2020 Category: International Medicine & Public Health Source Type: news

Hyperactive immune cells accelerate heart valve disease: Study
(RMIT University) Aortic valve stenosis is the most common type of heart valve disease in the elderly and affects more than one in eight people aged over 75. Researchers used organ-on-a-chip technology to discover the disease is made worse by the damaging hyperactivity of immune cells, which are activated by the constant stress of squeezing through the narrow aortic valve. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 8, 2020 Category: International Medicine & Public Health Source Type: news

New heart valve could transform open heart surgery for millions of patients globally
A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by scientists at the universities of Bristol and Cambridge. The team's latest in-vitro results, published in Biomaterials Science, suggest that the PoliValve could last for up to 25 years. (Source: University of Bristol news)
Source: University of Bristol news - June 29, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sciences, Institutes, Institutes, Bristol Heart Institute; Press Release Source Type: news

4D Flow MRI is feasible during exercise
Cardiac 4D flow MRI can quantify blood flow in the ascending aorta and main...Read more on AuntMinnie.comRelated Reading: AI speeds up reconstruction of 4D flow MRI MRI finds gender differences even in healthy hearts Advances in imaging, AI make cardiac MRI more accessible 4D flow MRI, 3D printing improve congenital heart surgery Heart valve-tracking algorithm boosts viability of 4D MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 19, 2020 Category: Radiology Source Type: news

Balloon-expandable vs. Self-expandable Transcatheter Valves Balloon-expandable vs. Self-expandable Transcatheter Valves
A new study finds that both self-expandable and balloon-expandable transcatheter heart valves can achieve excellent outcomes in the hands of experienced users.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 17, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

How Dangerous Is Percutaneous Heart Valve Replacement Surgery?
Title: How Dangerous Is Percutaneous Heart Valve Replacement Surgery?Category: Procedures and TestsCreated: 5/14/2020 12:00:00 AMLast Editorial Review: 5/14/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 14, 2020 Category: Cardiology Source Type: news

Best Practices for Human-Centric Design of Medical Devices
Medical devices designed to accommodate human variability present a growing opportunity for the healthcare and life sciences industries. Historically, medicine has solved many of the “simple” issues first: how to fix a broken leg has been known for centuries! But today we have treatments that didn’t even exist a generation ago, such as the use of stents and replacement valves for heart disease. These devices address a more limited cohort of people and are most successful when designed to be patient-specific. The cohorts themselves must also be further defined to account...
Source: MDDI - May 5, 2020 Category: Medical Devices Authors: Kristian Debus Tags: Design Source Type: news

CT helps predict TAVR outcomes
Identifying fibrotic lung disease on CT before transcathetor aortic valve replacement...Read more on AuntMinnie.comRelated Reading: 4D CT sheds light on post-TAVR treatment strategies 3D printing technique improves heart valve sizing 3D-printed aortas could work well for TAVR 3D printing helps evaluate leaks after TAVR procedures CT better than echo for aortic annulus before TAVR (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 4, 2020 Category: Radiology Source Type: news

Edwards Lifesciences Drops 2020 Revenue Guidance Due to COVID-19
While Edwards Lifesciences reported first-quarter sales growth of 14%, the structural heart company saw a steep drop in procedure volume in the last few weeks of the quarter due to COVID-19. "As you might expect, procedure volumes in March varied greatly by geography, even by hospital, as patients and providers turned their focus to the pandemic," CEO Mike Mussallem said during the company's first-quarter earnings call, according to a SeekingAlpha transcript. Mussallem said the company expects the impact of COVID-19 on its transcatheter aortic valve replacement (TAVR) sales to be most severe in the second quarter...
Source: MDDI - April 25, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news

With a heavy heart: How men and women develop heart disease differently
(McGill University) A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 24, 2020 Category: International Medicine & Public Health Source Type: news